Multivisceral transplant is a viable treatment option for patients with non ‐resectable intra‐abdominal fibromatosis

ConclusionsMultivisceral transplant (MVT) is a viable option for patients who have non‐resectable intra‐abdominal fibromatosis with promising surviving rates, although recurrence still occurs. Surgical margin, Ki67 proliferative index, β‐catenin, and p53 expression are not predicative for recurrence of fibromatosis.

Source: Clinical Transplantation - January 18, 2018 Category: Transplant Surgery Authors: Zhikai Chi, Richard S Mangus, Chandrashekhar A. Kubal, Shaoxiong Chen, Jingmei Lin Tags: ORIGINAL ARTICLE Source Type: research